The need to recognize the pulmonary circulation and the right ventricle as an integrated functional unit: Facts and hypotheses (2013 Grover conference series)

Pulmonary Circulation

Volumn 5, Issue 1, 2015, Pages 81-89

  Voelkel, Norbert F ^a   Bogaard, Harm Jan ^b   Gomez Arroyo, Jose ^c  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Autophagy; Capillary density; Hibernation; Right ventricle phenotypes

Indexed keywords

EID: 85026338040     PISSN: 20458932     EISSN: 20458940     Source Type: Journal    
DOI: 10.1086/679702     Document Type: Article

References (47)

1. Grover RF, Reeves JT. Exercise performance of athletes at sea level and 3100 meters altitude. Med Thorac 1966;23 (3):129-143.
2. Kay JM, Waymire JC, Grover RF. Lung mast cell hyperplasia and pulmonary histamine-forming capacity in hypoxic rats. Am J Physiol 1974;226(1):178-184.
3. Rounds SI, Moore LG, Voelkel NF, McMurtry IF, Reeves JT. Cardiac output is decreased and hypoxic vasoconstriction is intact in chronically hypoxic sheep. Proc Soc Exp Biol Med 1980;165(1):1-5.
4. Voelkel N, Reeves JT. Primary pulmonary hypertension. In: Moser KM, ed. Pulmonary vascular diseases. New York: Marcel Dekker, 1979:573-628.
5. Bristow MR, Zisman LS, Lowes BD, Abraham WT, Badesch DB, Groves BM, Voelkel NF, Lynch DM, Quaife RA. The pressure-overloaded right ventricle in pulmonary hypertension. Chest 1998;114(suppl):101S-106S.
6. Voelkel NF, Quaife RA, Leinwand LA, Barst RJ, McGoon MD, Meldrum DR, Dupuis J, et al.; National Heart Lung and Blood Institute Working Group on Cellular and Molecular Mechanisms of Right Heart Failure. Right ventricular function and failure: report of a National Heart, Lung, and Blood Institute Working Group on Cellular and Molecular Mechanisms of Right Heart Failure. Circulation 2006;114 (17):1883-1891.
7. Urashima T, Zhao M, Wagner R, Fajardo G, Farahani S, Quertermous T, Bernstein D. Molecular and physiological characterization of RV remodeling in a murine model of pulmonary stenosis. Am J Physiol Heart Circ Physiol 2008; 295(3):H1351-H1368.
8. Drake JI, Bogaard HJ, Mizuno S, Clifton B, Xie B, Gao Y, Dumur CI, Fawcett P, Voelkel NF, Natarajan R. Molecular signature of a right heart failure program in chronic severe pulmonary hypertension. Am J Respir Cell Mol Biol 2011; 45(6):1239-1247.
9. Gomez-Arroyo J, Mizuno S, Szczepanek K, Van Tassell B, Natarajan R, Remedios Dos CG, Drake JI, et al. Metabolic gene remodeling and mitochondrial dysfunction in failing right ventricular hypertrophy secondary to pulmonary arterial hypertension. Circ Heart Fail 2013;6(1):136-144.
10. Bogaard HJ, Natarajan R, Henderson SC, Long CS, Kraskauskas D, Smithson L, Ockaili R, McCord JM, Voelkel NF. Chronic pulmonary artery pressure elevation is insufficient to explain right heart failure. Circulation 2009;120 (20):1951-1960.
11. Sutendra G, Dromparis P, Paulin R, Zervopoulos S, Haromy A, Nagendran J, Michelakis ED. A metabolic remodeling in right ventricular hypertrophy is associated with decreased angiogenesis and a transition from a compensated to a decompensated state in pulmonary hypertension. J Mol Med 2013;91(11):1315-1327.
12. Piao L, Fang Y-H, Parikh KS, Ryan JJ, D’Souza KM, Theccanat T, Toth PT, et al. GRK2-mediated inhibition of adrenergic and dopaminergic signaling in right ventricular hypertrophy: therapeutic implications in pulmonary hypertension. Circulation 2012;126(24):2859-2869.
13. Rain S, Handoko ML, Trip P, Gan CT-J, Westerhof N, Stienen GJ, Paulus WJ, et al. Right ventricular diastolic impairment in patients with pulmonary arterial hypertension. Circulation 2013;128(18):2016-2025.
14. Piao L, Fang Y-H, Cadete VJJ, Wietholt C, Urboniene D, Toth PT, Marsboom G, et al. The inhibition of pyruvate dehydrogenase kinase improves impaired cardiac function and electrical remodeling in two models of right ventricular hypertrophy: resuscitating the hibernating right ventricle. J Mol Med 2010;88(1):47-60.
15. May D, Gilon D, Djonov V, Itin A, Lazarus A, Gordon O, Rosenberger C, Keshet E. Transgenic system for conditional induction and rescue of chronic myocardial hibernation provides insights into genomic programs of hibernation. Proc Natl Acad Sci USA 2008;105(1):282-287.
16. Bogaard HJ, Abe K, Vonk Noordegraaf A, Voelkel NF. The right ventricle under pressure: cellular and molecular mechanisms of right-heart failure in pulmonary hypertension. Chest 2009;135(3):794-804.
17. Yet SF, Perrella MA, Layne MD, Hsieh CM, Maemura K, Kobzik L, Wiesel P, Christou H, Kourembanas S, Lee ME. Hypoxia induces severe right ventricular dilatation and infarction in heme oxygenase-1 null mice. J Clin Invest 1999;103(8):R23-R29.
18. Bogaard HJ, Natarajan R, Mizuno S, Abbate A, Chang PJ, Chau VQ, Hoke NN, Kraskauskas D, Kasper M, Salloum FN, Voelkel NF. Adrenergic receptor blockade reverses right heart remodeling and dysfunction in pulmonary hypertensive rats. Am J Respir Crit Care Med 2010;182 (5):652-660.
19. de Man FS, Handoko ML, van Ballegoij JJM, Schalij I, Bogaards SJP, Postmus PE, van der Velden J, Westerhof N, Paulus WJ, Vonk Noordegraaf A. Bisoprolol delays progression towards right heart failure in experimental pulmonary hypertension. Circ Heart Fail 2012;5(1):97-105.
20. Choi AMK, Ryter SW, Levine B. Autophagy in human health and disease. N Engl J Med 2013;368(7):651-662.
21. Gottlieb RA, Mentzer RM. Autophagy during cardiac stress: joys and frustrations of autophagy. Annu Rev Physiol 2010; 72(1):45-59.
22. Maiuri MC, Zalckvar E, Kimchi A, Kroemer G. Self-eating and self-killing: crosstalk between autophagy and apoptosis. Nat Rev Mol Cell Biol 2007;8(9):741-752.
23. Willis MS, Patterson C. Proteotoxicity and cardiac dysfunction—Alzheimer’s disease of the heart? N Engl J Med 2013; 368(5):455-464.
24. Gottlieb RA, Carreira RS. Autophagy in health and disease. 5. Mitophagy as a way of life. Am J Physiol Cell Physiol 2010;299(2):C203-C210.
25. Klionsky DJ. Autophagy: from phenomenology to molecular understanding in less than a decade. Nat Rev Mol Cell Biol 2007;8(11):931-937.
26. He C, Klionsky DJ. Regulation mechanisms and signaling pathways of autophagy. Annu Rev Genet 2009;43:67-93.
27. Rotter D, Rothermel BA. Targets, trafficking, and timing of cardiac autophagy. Pharmacol Res 2012;66(6):494-504.
28. Ma X, Liu H, Foyil SR, Godar RJ, Weinheimer CJ, Hill JA, Diwan A. Impaired autophagosome clearance contributes to cardiomyocyte death in ischemia/reperfusion injury. Circulation 2012;125(25):3170-3181.
29. de Man FS, Handoko ML, Guignabert C, Bogaard HJ, Vonk Noordegraaf A. Neurohormonal axis in patients with pulmonary arterial hypertension: friend or foe? Am J Respir Crit Care Med 2013;187(1):14-19.
30. Voelkel NF, Gomez-Arroyo J, Abbate A, Bogaard HJ, Nicolls MR. Pathobiology of pulmonary arterial hypertension and right ventricular failure. Eur Respir J 2012;40(6): 1555-1565.
31. Morrell NW, Adnot S, Archer SL, Dupuis J, Jones PL, MacLean MR, McMurtry IF, et al. Cellular and molecular basis of pulmonary arterial hypertension. J Am Coll Cardiol 2009;54(suppl):S20-S31.
32. Hopkins WE, Waggoner AD. Severe pulmonary hypertension without right ventricular failure: the unique hearts of patients with Eisenmenger syndrome. Am J Cardiol 2002; 89(1):34-38.
33. Zhang Q, Raoof M, Chen Y, Sumi Y, Sursal T, Junger W, Brohi K, Itagaki K, Hauser CJ. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 2010;464(7285):104-107.
34. Wang J-G, Williams JC, Davis BK, Jacobson K, Doerschuk CM, Ting JP-Y, Mackman N. Monocytic microparticles activate endothelial cells in an IL-1β-dependent manner. Blood 2011;118(8):2366-2374.
35. Deregibus MC, Cantaluppi V, Calogero R, Iacono Lo M, Tetta C, Biancone L, Bruno S, Bussolati B, Camussi G. Endothelial progenitor cell derived microvesicles activate an angiogenic program in endothelial cells by a horizontal transfer of mRNA. Blood 2007;110(7):2440-2448.
36. Rando TA, Finkel T. Cardiac aging and rejuvenation—a sense of humors? N Engl J Med 2013;369(6):575-576.
37. Nagendran J, Archer SL, Soliman D, Gurtu V, Moudgil R, Haromy A, St Aubin C, et al. Phosphodiesterase type 5 is highly expressed in the hypertrophied human right ventricle, and acute inhibition of phosphodiesterase type 5 improves contractility. Circulation 2007;116(3):238-248.
38. Nagendran J, Sutendra G, Paterson I, Champion HC, Webster L, Chiu B, Haromy A, Rebeyka IM, Ross DB, Michelakis ED. Endothelin axis is upregulated in human and rat right ventricular hypertrophy. Circ Res 2013;112(2):347-354.
39. Alzoubi A, Toba M, Abe K, O’Neill KD, Rocic P, Fagan KA, McMurtry IF, Oka M. Dehydroepiandrosterone restores right ventricular structure and function in rats with severe pulmonary arterial hypertension. Am J Physiol Heart Circ Physiol 2013;304(12):H1708-H1718.
40. Spiekerkoetter E, Tian X, Cai J, Hopper RK, Sudheendra D, Li CG, El-Bizri N, et al. FK506 activates BMPR2, rescues endothelial dysfunction, and reverses pulmonary hypertension. J Clin Invest 2013;123(8):3600-3613.
41. Syed A, Gomez-Arroyo J, Sakagami M, Farkas L, Farkas D, Al-Hussaini AA, Kraskauskas D. P. B, Voelkel NF. Inhaled iloprost improves right ventricular function in the Sugen5416/hypoxia model of severe pulmonary hypertension. Eur Respir J 2014, September 26 (Epub ahead of print).
42. Zabini D, Nagaraj C, Stacher E, Lang IM, Nierlich P, Klepetko W, Heinemann A, Olschewski H, Bálint Z, Olschewski A. Angiostatic factors in the pulmonary endarterectomy material from chronic thromboembolic pulmonary hypertension patients cause endothelial dysfunction. PLoS ONE 2012;7(8): e43793.
43. Sandoval J, Gaspar J, Peña H, Santos LE, Córdova J, del Valle K, Rodríguez A, Pulido T. Effect of atrial septostomy on the survival of patients with severe pulmonary arterial hypertension. Eur Respir J 2011;38(6):1343-1348.
44. Shimano M, Ouchi N, Walsh K. Cardiokines: recent progress in elucidating the cardiac secretome. Circulation 2012; 126(21):e327-e332.
45. Champion HC, Michelakis ED, Hassoun PM. Comprehensive invasive and noninvasive approach to the right ventricle-pulmonary circulation unit: state of the art and clinical and research implications. Circulation 2009;120 (11):992-1007.
46. Vonk Noordegraaf A, Westerhof N. Describing right ventricular function. Eur Respir J 2013;41(6):1419-1423.
47. Vonk Noordegraaf A, Haddad F, Chin KM, Forfia PR, Kawut SM, Lumens J, Naeije R, et al. Right heart adaptation to pulmonary arterial hypertension: physiology and pathobiology. J AmColl Cardiol 2013;62(suppl):D22-D33.